Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Approaches for skeletal gene therapy.

Christopher Niyibizi1, Corey J Wallach, Zhibao Mi

  • 1Department of Orthopaedic Surgery, Ferguson Laboratories for Orthopaedic Research, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. niyi@pitt.edu

Critical Reviews in Eukaryotic Gene Expression
|November 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A transcriptomic analysis reveals shared and inducer-specific expression patterns of cellular senescence.

bioRxiv : the preprint server for biology·2026
Same author

Ensemble of Time-Evolving SASP Gene Sets Identifies IGFBP7 and CDKN1A as a Potential Marker Pair for Senescent Fibroblast Subpopulations Across Tissues.

International journal of molecular sciences·2026
Same author

Tomatidine is a senotherapeutic compound that improves cognitive function and reduces cellular senescence in aged mice.

EMBO molecular medicine·2026
Same author

The ageing immune system as a driver of systemic ageing.

Nature reviews. Immunology·2026
Same author

Osteoarthritis Gene Therapy: A 30-Year Journey From Concept to Clinical Trials.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2026
Same author

Senotoxins target senescence via lipid binding specificity, ion imbalance and lipidome remodeling.

Nature aging·2026

Gene therapy research for musculoskeletal disorders is advancing. For osteogenesis imperfecta (OI), combined gene manipulation and cell transplantation show promise, overcoming challenges of dominant negative mutations.

Area of Science:

  • Orthopedics and Regenerative Medicine
  • Molecular Genetics and Gene Therapy

Background:

  • Musculoskeletal disorders are increasingly understood at the etiological level.
  • Osteogenesis imperfecta (OI) is a group of genetic disorders affecting connective tissue integrity due to type I collagen gene mutations.

Purpose of the Study:

  • To review current gene and cell therapy strategies for treating osteogenesis imperfecta (OI).
  • To explore novel approaches for OI treatment, considering the limitations of traditional gene replacement.

Main Methods:

  • Review of laboratory and clinical advances in cell therapy for OI.
  • Investigation of antisense gene therapy to suppress mutant allele expression.
  • Exploration of methods for delivering collagen genes to bone cells.

Related Experiment Videos

Main Results:

  • Combined genetic manipulation and cellular transplantation offer a potential strategy for OI treatment.
  • Antisense gene therapy and gene delivery techniques are under investigation.
  • Significant challenges remain in developing effective skeletal gene therapies.

Conclusions:

  • Gene and cell therapy hold promise for treating osteogenesis imperfecta.
  • Overcoming dominant negative mutations requires innovative therapeutic combinations.
  • Continued research is essential to address the challenges in skeletal gene therapy for OI.